Discover 162 paid clinical trials in Wilmington, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 162
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
for
Diabetes Mellitus, Type 2, Obesity
Location: Wilmington NC, Myrtle Beach SC, Morehead City NC,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Studies for Adults With Type 2 Diabetes and an A1C Between 7% and 10.5%
for
Diabetes Mellitus, Type 2
Location: Wilmington NC, Myrtle Beach SC, Morehead City NC,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Study for Adults With Type 2 Diabetes and Heart Disease or Heart Risk Factors
for
Diabetes Mellitus, Type 2, Cardiovascular Diseases
Location: Wilmington NC, Myrtle Beach SC, Morehead City NC,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Study for Adults With Type 2 Diabetes Who Take Daily Insulin
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
for
Obesity, Overweight and/or Obesity, Overweight
Location: Wilmington NC, Greensboro NC, Norfolk VA, Baltimore MD,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07595549
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
for
Sjögren´s Disease
Location: Wilmington NC, Charlotte NC, Voorhees Township NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07621809
Phase 3, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Wilmington NC, Little River SC, Kinston NC, Durham NC,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase 3, Recruiting
Active & Responsive
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Wilmington NC, Morehead City NC, Raleigh NC,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase 3, Recruiting
Active & Responsive
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Wilmington NC, Morehead City NC, Greenville NC, Cary NC,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Wilmington NC, Morehead City NC, Cary NC, Raleigh NC,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07816367
Phase 3, Recruiting
Active & Responsive
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
for
Degenerative Disc Disease
Location: Wilmington NC, Winston-Salem NC, Richmond VA,
Sponsor: DiscGenics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07254806
Phase 3, Recruiting
Active & Responsive
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
for
Schizophrenia
Location: Wilmington NC, Cary NC, Atlanta GA, Austell GA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07379827
Recruiting
Active & Responsive
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis (AD)
Location: Wilmington NC, Norfolk VA, Atlanta GA, Camp Hill PA,
Sponsor: Enveda Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07298395
Phase 2, Recruiting
Active & Responsive
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis